这次批准的依据是2次前瞻性随机双盲安慰剂控制对照临床研究的数据。
The approval was based on data from 2 prospective, randomized, double-blind placebo-controlled clinical studies.
双盲，安慰剂控制在80接触性皮炎患者的研究将在以色列哈达萨医院进行。
The double-blind, placebo-controlled study on 80 contact dermatitis patients will take place at the Hadassah Hospital in Israel.
我们的产品已在众多双盲，安慰剂控制的临床研究的安全性和疗效的临床试验。
Our products have been clinically tested for safety and efficacy in numerous double-blind, placebo controlled clinical studies.
四个安慰剂控制的试验发现没有证据支持抗忧郁剂可以改善体重增加、厌食症或相关的精神病理。
Four placebo-controlled trials did not find evidence that antidepressants improved weight gain, eating disorder or associated psychopathology.
为了控制参与者的咖啡因吸收量，研究组给他们含有大约相当于一天四杯咖啡的咖啡因药片，或者外表相似的安慰剂药片。
To control the amount of caffeine the participants received, the team gave them pills containing caffeine equivalent to around four cups of coffee in one day or similar looking placebos.
实验的参与者被随机分配到每天都服用绿茶饮料或胶囊制品的实验组和服用安慰剂胶囊和喝低儿茶素的茶或者更直接饮用水的控制组。
Participants were randomly assigned to either use green tea every day, as a beverage or capsule, or be part of "control" groups that took placebo capsules, drank a low-catechin tea or downed water.
令人遗憾的是，他们并没有包括控制组，也没有考虑安慰剂效应的可能性。
Regrettably, they did not include a control group and did not entertain the possibility of placebo effects.
这项回顾显示4%的服用抗抑郁剂的儿童或青少年考虑或企图自杀(尽管没有自杀发生)，而服用安慰剂的控制组仅2%。
The review revealed that 4% of those taking antidepressants thought about or attempted suicide (although no suicides occurred), compared to 2% of those receiving placebos.
关于安慰剂效应，已知的一点是它涉及到了几个大脑系统，每一个都由一种特殊的信使分子控制，称为“神经递质”。
One thing that is known about the placebo effect is that it involves several brain systems, each under the control of a particular type of messenger molecule, called a neurotransmitter.
对于服用安慰剂的患者，我们可以减少他们口服类固醇药物的剂量，但是除了一两名患者以外，其他患者的哮喘症状加重，更难控制。
For the folks who took the placebo, we were able to reduce their oral steroid load, but in all but one or two people, this was associated with a worsening of their asthma control.
控制组的治疗方案包括安慰剂，常规护理和非噻唑啉二酮类药物抗糖尿病治疗。
Treatments used in the control groups included placebo, usual care, and non-TZD antidiabetic therapies.
给予利莫那班的病人同时腰围、血糖、血脂有很大改善，并且与安慰剂组相比病人能够更好的控制自己的食欲。
Patients given rimonabant also had greater improvements in waist circumference, blood glucose control, blood lipids, and better appetite control than those given the placebo.
对已知的对屋内尘（虫满）过敏的气喘病患采取尘（虫满）控制监测或安慰剂治疗或不治疗的随机试验，。
We included randomised trials of mite control measures versus placebo or no treatment in people with asthma known to be sensitive to house dust mites.
入院接受密集化疗的血液学恶性肿瘤的病人被随机分为两组，在单中心实验中用双盲法处理安慰剂组和控制组。
Patients with haematological malignancies receiving intensive chemotherapy and requiring hospitalization were randomized in a double-blind, placebo-controlled single-centre trial.
入院接受密集化疗的血液学恶性肿瘤的病人被随机分为两组，在单中心实验中用双盲法处理安慰剂组和控制组。
Patients with haematological malignancies receiving intensive chemotherapy and requiring hospitalization were randomized in a double-blind, placebo-controlled single-centre trial.
应用推荐